Vaccine and Vector
Development
Development
We provide hands-on training for recipient teams on the technology, its applications, and operational requirements.
Vaccine Development Services
Vaccine development has progressed from traditional prophylactic applications to more advanced and innovative therapeutic products. A prophylactic vaccine aims to prevent future infections by natural pathogens, while a therapeutic vaccine specifically targets cancer. Typically, vaccines are based on inactivated or dead native pathogens, or pathogen analogs. In this context, we provide a brief overview of the role of exosomes in vaccine development. Additionally, to support exosome research, we offer a wide range of exosome-related services designed to assist in vaccine development.
Vector Development Services
Gene therapy is an emerging and promising approach for treating cancer and genetic disorders by introducing foreign genetic material into host cells to achieve therapeutic benefits.
The success of gene therapy largely depends on the development of safe and efficient gene delivery systems.
Viral vectors are particularly effective at infecting cells and transferring DNA to the host without triggering an immune response. To ensure safety, viral vectors are engineered to be replication-incompetent. Due to their efficacy and specificity, viral vectors have become the cornerstone of clinical trials in gene therapy.
We offer a comprehensive range of viral vectors and advanced viral vector technologies for basic research and preclinical applications. Our services include the design and construction of customized viral vectors, as well as small to large-scale viral vector production.
We have the broad capabilities and expertise from the design to production of viral vectors, with in-depth viral vector technical and expertise, we can help you de-risk and expedite your therapy's path to market.